The oncogenicity of Epstein-Barr virus.
D000349:Africa; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000918:Antibody Specificity; D000956:Antigens, Viral / Q000032:analysis; D002051:Burkitt Lymphoma / Q000276:immunology / Q000382:microbiology; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D002681:China; D000882:Haplorhini; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D066298:In Vitro Techniques; D007244:Infectious Mononucleosis / Q000209:etiology / Q000382:microbiology; D007962:Leukocytes; D009303:Nasopharyngeal Neoplasms / Q000276:immunology / Q000382:microbiology; D009374:Neoplasms, Experimental; D009858:Oncogenic Viruses; D014764:Viral Proteins / Q000032:analysis
D000914:Antibodies, Viral; D000956:Antigens, Viral; D014764:Viral Proteins